Why the McPherson's (ASX:MCP) share price could charge higher on Tuesday

The McPherson's Ltd (ASX:MCP) share price will be one to watch on Tuesday following an after market update today…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The McPherson's Ltd (ASX: MCP) share price will be on watch on Tuesday following the release of a trading update after the market close.

What did McPherson's announce?

This afternoon McPherson's confirmed that sales from its core brands in the Australian market continue to exceed last year's figures.

According to the release, year to date, the company's owned brands, excluding the Dr. LeWinn's brand, have recorded sales growth of 7%.

This has been driven by double digit sales growth from the Manicare, Lady Jayne, and A'kin brands. Furthermore, market share growth has been recorded from 4 out of 6 of its owned brands.

The Dr. LeWinn's brand continues to weigh on the company's performance, though. Like A2 Milk Company Ltd (ASX: A2M), this has been caused by weakness in the daigou channel.

However, unlike a2 Milk, the sales of these products inside China haven't been strong, with Chinese Singles' Day sales falling well short of expectations.

Global Therapeutics acquisition.

In addition to this, the company revealed that the Global Therapeutics acquisition from Blackmores Limited (ASX: BKL) completed successfully on 30 November and its integration is progressing smoothly.

Management believes that this reflects the professional, collaborative approach of Global Therapeutics, McPherson's, and Blackmores.

McPherson's new Chief Executive Officer and Managing Director, Grant Peck, commented: "McPherson's year to date domestic sales growth reflects the consumer appeal of our market leading brands and our focus on new product innovation. All of the early signs are positive as we integrate Global Therapeutics into McPherson's and realise the complementary capabilities of the combined teams. Domestically, we continue to drive cashflow to support our mature dividend profile and modest debt levels."

Mr Peck, who was appointed CEO earlier this month after the sudden departure of Laurie McAllister following a series of terrible updates, also provided the market with guidance for the first half of FY 2021.

He revealed that McPherson's is on track to achieve its previous first half underlying profit before tax guidance in the range of $6.5 million to $7.5 million. This represents an 11.8% to 23.5% decline on the prior corresponding period's profit before tax of $8.5 million.

In addition to this, the new chief executive revealed that shareholders should expect a dividend March. He advised that the company's dividend policy is to pay a minimum dividend of 60% of underlying profit after tax, subject to cash requirements.

In line with this policy and based on its forecast first half underlying earnings, an interim fully franked dividend of at least 3 cents per share is expected to be paid to shareholders in March.

Annualised, this represents a fully franked 4.5% dividend yield. This may be far better than many had expected after its recent updates and guidance withdrawal.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk and Blackmores Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors lost some of this week's mojo this Thursday.

Read more »

Man in suit plummets downwards in sky.
Share Fallers

This ASX stock just crashed 24% after a $1.7bn deal. Here's what spooked investors

Investors dump Maas shares despite a $1.7 billion dollar deal.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

Morgans names 2 ASX shares to buy now

The broker has good things to say about these shares.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

5 ASX 200 shares forecast to soar 100% (or more) in 2026

Are any of these in your portfolio already?

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Opinions

Why I'm bullish on these buy-rated ASX shares in February

When execution, growth, and industry trends align, I’m much more willing to lean bullish.

Read more »

A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
Share Fallers

Why Beach Energy, Elders, Maas, and Neuren shares are dropping today

These shares are under pressure on Thursday. But why?

Read more »

a group of rockclimbers attached to each other with a rope hang precariously from a steep cliff face with the bottom two climbers not touch the rockface but dangling in midair held only by the rope.
52-Week Lows

Bargain hunting? Here are 3 ASX 200 shares plumbing 52-week lows today

Investors just sent these three ASX 200 stocks tumbling to multi-year lows. Time to pounce?

Read more »

A miner stands in front of an excavator at a mine site.
Capital Raising

Why this ASX uranium miner's shares are frozen today

This ASX uranium miner is halted as the market waits for further clarity.

Read more »